1. Home
  2. NERV vs MHUA Comparison

NERV vs MHUA Comparison

Compare NERV & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • MHUA
  • Stock Information
  • Founded
  • NERV 2007
  • MHUA 1990
  • Country
  • NERV United States
  • MHUA China
  • Employees
  • NERV N/A
  • MHUA N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • NERV Health Care
  • MHUA Health Care
  • Exchange
  • NERV Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • NERV 12.0M
  • MHUA 13.4M
  • IPO Year
  • NERV 2014
  • MHUA 2022
  • Fundamental
  • Price
  • NERV $2.35
  • MHUA $0.37
  • Analyst Decision
  • NERV Hold
  • MHUA
  • Analyst Count
  • NERV 1
  • MHUA 0
  • Target Price
  • NERV $5.00
  • MHUA N/A
  • AVG Volume (30 Days)
  • NERV 41.4K
  • MHUA 53.9K
  • Earning Date
  • NERV 11-04-2025
  • MHUA 09-19-2025
  • Dividend Yield
  • NERV N/A
  • MHUA N/A
  • EPS Growth
  • NERV N/A
  • MHUA N/A
  • EPS
  • NERV 1.48
  • MHUA 0.40
  • Revenue
  • NERV N/A
  • MHUA $96,909,642.00
  • Revenue This Year
  • NERV N/A
  • MHUA N/A
  • Revenue Next Year
  • NERV N/A
  • MHUA N/A
  • P/E Ratio
  • NERV $1.58
  • MHUA $0.93
  • Revenue Growth
  • NERV N/A
  • MHUA N/A
  • 52 Week Low
  • NERV $1.15
  • MHUA $0.25
  • 52 Week High
  • NERV $3.00
  • MHUA $1.24
  • Technical
  • Relative Strength Index (RSI)
  • NERV 59.22
  • MHUA 37.52
  • Support Level
  • NERV $2.26
  • MHUA $0.36
  • Resistance Level
  • NERV $2.47
  • MHUA $0.44
  • Average True Range (ATR)
  • NERV 0.15
  • MHUA 0.02
  • MACD
  • NERV -0.01
  • MHUA -0.00
  • Stochastic Oscillator
  • NERV 36.71
  • MHUA 12.99

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: